CASI Pharmaceuticals, Inc. CASIF
0.10 USD -0.02 (-14.89%)
Nov 3, 2026, 3:33 PM EST
0.10 Day range 0.105
0.05 52-week range 1.48
- YTD
- -88.24%
- 1 year
- -92.81%
- Market cap
- 2.06M
- EPS (ttm)
- -2.00
- YTD return
- -88.24%
- 1-year return
- -92.81%
- Volume
- 145
- Avg volume
- 2.15K
- Open
- 0.105
- Previous close
- 0.1175
- Day's range
- 0.10 – 0.105
- 52-week range
- 0.05 – 1.48
2Y -6.0400 (-98.37%)
News
What Drove CASI Pharmaceuticals' 24% Rise After Hours? 
CASI Pharmaceuticals Receives the Delisting Decision From the Nasdaq Hearings Panel 
CASI Pharmaceuticals Announces Approval of Clinical Trial Application by China NMPA for Phase 1 / 2 Study of CID-103 for Renal Allograft Antibody-Mediated Rejection (AMR) 
CASI Pharmaceuticals Announces Update and Additional Results from Phase 1 Study of CID-103 in Adult Patients with Chronic Immune Thrombocytopenia 
CASI Pharmaceuticals Receives Extension from Nasdaq to Meet Listing Requirements 
CASI Pharmaceuticals Announces Up to $20 Million Convertible Note Financing 
CASI Pharmaceuticals Announces Results from CID-103 Immune Thrombocytopenia Study at the 67th American Society of Hematology (ASH) Annual Meeting 
CASI Pharmaceuticals Announces Changes in Board Governance 
CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results 
CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ
Your note
Sign in to keep a note on CASIF — it syncs with the Stock Master app.